Russell Frank Company’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$636K Buy
18,942
+14,046
+287% +$442K ﹤0.01% 2368
2015
Q4
$153K Sell
4,896
-61,992
-93% -$2.09M ﹤0.01% 2739
2015
Q3
$2.11M Sell
66,888
-15,371
-19% -$750K ﹤0.01% 1809
2015
Q2
$3.98M Buy
82,259
+28,844
+54% +$1.22M 0.01% 1570
2015
Q1
$2.31M Sell
53,415
-34,597
-39% -$1.24M ﹤0.01% 1693
2014
Q4
$2.33M Hold
88,012
﹤0.01% 1694
2014
Q3
$1.56M Buy
+88,012
New +$1.8M ﹤0.01% 1857
2014
Q2
Sell
-55,053
Closed -$1.01M 2829
2014
Q1
$1.01M Sell
55,053
-9,891
-15% -$274K ﹤0.01% 2090
2013
Q4
$1.4M Buy
64,944
+290
+0.4% +$5.86K ﹤0.01% 1916
2013
Q3
$1.46M Buy
+64,654
New +$1.49M ﹤0.01% 2005

Other funds holding PGEN

Russell Frank Company's PGEN Position: Q1 2016 in Review

Russell Frank Company increased its Precigen (PGEN) stake by 287% in Q1 2016, buying an estimated $442K and bringing the position to 18,942 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Russell Frank Company first reported a position in PGEN in Q3 2013 and has held it in 10 quarters since. The position peaked at $3.98M in Q2 2015. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • Russell Frank Company held 18,942 shares of Precigen worth $636K as of Q1 2016.
  • Russell Frank Company bought 14,046 Precigen shares in Q1 2016, an estimated $442K.
  • Precigen made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2368 holding.
  • Russell Frank Company first reported a position in Precigen in Q3 2013 and has held it in 10 quarters since.
  • Russell Frank Company's Precigen position peaked at $3.98M in Q2 2015.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.